Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition

D. Oosterhoff, S.M. Lougheed, R. van de Ven, J.J. Lindenberg, H. van Cruijsen, L. Hiddingh, J. Kroon, A.J.M. van den Eertwegh, B. Hangalapura, R.J. Scheper, T.D. de Gruijl

Research output: Contribution to journalArticleAcademicpeer-review

50 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)649-658
JournalOncoimmunology
Volume1
Issue number5
DOIs
Publication statusPublished - 2012

Cite this